[HTML][HTML] A genetics-guided approach to the clinical management of schizophrenia

AD Besterman - Schizophrenia Research, 2023 - Elsevier
Schizophrenia is a highly heritable, severe mental illness characterized by hallucinations,
delusions, social withdrawal, and cognitive dysfunction present in∼ 1% of populations …

The landscape of the methodology in drug repurposing using human genomic data: a systematic review

L Wang, Y Lu, D Li, Y Zhou, L Yu… - Briefings in …, 2024 - academic.oup.com
The process of drug development is expensive and time-consuming. In contrast, drug
repurposing can be introduced to clinical practice more quickly and at a reduced cost. Over …

[HTML][HTML] Genetic influences on circulating retinol and its relationship to human health

WR Reay, DJ Kiltschewskij, MA Di Biase… - Nature …, 2024 - nature.com
Retinol is a fat-soluble vitamin that plays an essential role in many biological processes
throughout the human lifespan. Here, we perform the largest genome-wide association …

[HTML][HTML] Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis

TL Warren, JD Tubbs, TA Lesh, MB Corona… - Molecular …, 2024 - nature.com
A primary goal of psychiatry is to better understand the pathways that link genetic risk to
psychiatric symptoms. Here, we tested association of diagnosis and endophenotypes with …

Exploring opportunities for drug repurposing and precision medicine in cannabis use disorder using genetics

LA Greco, WR Reay, CV Dayas, MJ Cairns - Addiction biology, 2023 - Wiley Online Library
Cannabis use disorder (CUD) remains a significant public health issue globally, affecting up
to one in five adults who use cannabis. Despite extensive research into the molecular …

Poor sleep quality in schizophrenia patients: A systematic review and meta-analyses of epidemiological and case-control studies

MY Chen, YY Wang, TL Si, YF Liu, Z Su… - Schizophrenia …, 2024 - Elsevier
Objective Poor sleep quality is common in patients with schizophrenia but estimated
prevalence rates in this population have been mixed. This systematic review and meta …

[HTML][HTML] Artificial intelligence ecosystem for computational psychiatry: Ideas to practice

XQ Liu, XY Ji, X Weng, YF Zhang - World Journal of Meta-Analysis, 2023 - wjgnet.com
Computational psychiatry is an emerging field that not only explores the biolo gical basis of
mental illness but also considers the diagnoses and identifies the underlying mechanisms …

Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension

WR Reay, E Clarke, S Eslick, C Riveros, EG Holliday… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Hypertension is a key risk factor for major adverse cardiovascular events
but remains difficult to treat in many individuals. Dietary interventions are an effective …

Challenges, unmet needs and future directions–a critical evaluation of the clinical trial landscape in schizophrenia research

E Wagner, JJ Luykx, W Strube… - Expert Review of Clinical …, 2024 - Taylor & Francis
Introduction Developing novel antipsychotic mechanisms of action and repurposing
established compounds for the treatment of schizophrenia is of utmost importance to …

Large-Scale Mendelian Randomization Study Reveals Circulating Blood-based Proteomic Biomarkers for Psychopathology and Cognitive Task Performance

U Bhattacharyya, J John, M Lam, J Fisher, B Sun… - medRxiv, 2024 - medrxiv.org
Background: Research on peripheral (eg, blood-based) biomarkers for psychiatric illness
has typically been low-throughput in terms of both the number of subjects and the range of …